CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 144 Insider Sale of Securities
- UPLOAD Other SEC-generated Letter
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Gift Director gave 301,457 shares (gift)
- 4 Grant or award Chief Financial Officer acquired 118,547 shares (grant or award)
- S-4 Deal Registration Statement - Business Combination
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 4 Open-market sale SVP, General Counsel sold 834 shares at $160.57 ($133,915)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 144 Insider Sale of Securities
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market sale Chief Financial Officer sold 472 shares at $143.90 ($67,919)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Financial Officer sold 899 shares at $155.66 ($139,938)
- 4 Open-market sale Global Head of R&D sold 1,064 shares at an average $159.80 ($170,030)
Page 19 of 64 · 1,278 filings